Passengers with special needs or who require assistance at the airport or in flight may note this in the memo field if booking on-line. Public Charters will do our best to ensure our passengers are accommodated with their special needs. Please call 877-359-7595 for more details or to add this information into an existing reservation.
Passengers with disabilities can obtain a copy of 14 CFR Part 382 Regulations in an accessible format from the Department of Transportation by any of the following means:
(1) For calls made from within the United States, by telephone via the Toll-Free Hotline for Air Travelers with Disabilities at 1-800-778-4838 (voice) or 1-800-455-9880 (TTY),
(2) By telephone to the Aviation Consumer Protection Division at 202-366-2220 (voice) or 202-366-0511 (TTY),
(3) By mail to the Air Consumer Protection Division, C-75, U.S. Department of Transportation, 1200 New Jersey Ave., SE., West Building, Room W96-432, Washington, DC 20590, and
(4) On the Aviation Consumer Protection Division’s Web site (http://www.dot.gov/airconsumer)
Wheelchair Assistance at the Airport
Passengers who need a wheelchair from their departing airport may request one from Check-In or Gate staff at the airport while checking in on the day of travel. If wheelchair assistance is needed from the curb, passengers may request one from any available Sky Cap.
Should a wheelchair be needed at their arriving airport gate, passenger should notify the check-in staff from their departing airport, who in turn will notify the arriving airport.
Portable Oxygen Concentrators
Passengers traveling with portable oxygen concentrators on Public Charters, Inc. flights must adhere to the following requirements:
The following portable oxygen concentrators are approved for use on CFM aircraft:
|Inogen One||Delphi RS-00400|
|Invacare XP02||AirSep Lifestyle *|
|AirSep Freestyle||SeQual Eclipse|
• *The AirSep Lifestyle device must have a sticker affixed to the inside cover stating “RTCA/DO—1600 21 category M Compliant” to indicate that it has been modified for air travel. If the AirSep Lifestyle Device does not have this sticker; it will not be accepted for use on board.
• Portable oxygen concentrators can’t be used when seated at an exit row or bulkhead seat.
• Passenger must provide a letter from a licensed physician that:
o States user has the physical and cognitive ability to take appropriate action in response to cautions and warnings broadcast by the oxygen concentrator o States whether or not oxygen use is medically necessary for all or a portion of a trip,
o Specifies the maximum oxygen flow rate corresponding to the pressure in the cabin of the aircraft under normal operating conditions.
• Portable oxygen concentrators not listed above may not be used on board. They will be permitted as
carry-on or checked baggage only under the following conditions:
o It must be empty and free of pressure.
o The battery should be removed and packaged separately or o It should have a recessed
battery terminal and the packaged battery terminals should not contact any metal objects.
• When not in use, the device must be stowed under the seat in front of the user or in stowage
location so that it does not block an aisle or the entryway into the row. Personal oxygen systems containing liquid oxygen are not accepted on board.
The following portable oxygen concentrators are approved for use on Xtra Airways aircraft:
|AirSep Free Style||Invacare XP02|
|AirSep Lifestyle||Invacare Solo2|
|DeVilbiss Healthcare iGo||Inva Labs LifeChoice|
|Inogen One||Oxlife Independence Oxygen Concentrator|
|Inogen One G2||Oxus, Inc. RS-00400|
|Invcare XP02||SeQual Eclipse Portable Oxygen Concentrator|
Passengers traveling with an Approved Concentrator must provide a copy of a physician’s note to Public Charters, Inc. within 7 days of booking their travel, but not less than 72 hours prior to departure. The physician’s note must be kept in the passenger’s possession, signed by a licensed physician and state the following:
- States whether the user of the device has the physical and cognitive ability to see, hear, and understand the device’s aural and visual cautions and warnings and is able, without assistance, to take the appropriate action in response to those cautions and warnings;
2. States whether or not oxygen use is medically necessary for all or a portion of the durations of the trip; and
3. Specifies the maximum oxygen flow rate corresponding to the pressure in the cabin of the aircraft under normal operating conditions.
The physician’s note should be sent to Public Charters as follows:
- By email to: email@example.com; or
- By fax to: 570-457-4113; or
- By mail to:
Public Charters, Inc.
Wilkes Barre/Scranton Int’l Airport
201 Hangar Road
Avoca, PA 18641
Failure to submit a physician’s note within the time restraints stated above will result in denied boarding and subsequent forfeiture of the price of their ticket.
The user must ensure that the portable oxygen concentrator is free of oil, grease or other petroleum products and is in good condition free from damage or other signs of excessive wear or abuse.
Only lotions or salves that are oxygen approved may be used by persons using the portable oxygen concentrator device.
The user, whose physician statement specifies the duration of oxygen use, must obtain the duration of the planned flight. The user must carry on the flight a sufficient number of batteries to power the device for the duration of the oxygen use specified in the user’s physician statement, including a conservative estimate of any unanticipated delays; and
The user must ensure that all portable oxygen concentrator batteries carried onboard the aircraft in carry-on baggage are protected from damage. Batteries protected from short circuit include: (1) Those designed with recessed battery terminals; or (2) those packaged so that the battery terminals do not contact metal objects (including the battery terminals of other batteries). When a battery-powered oxygen concentrator is carried onboard aircraft as carry-on baggage and is not intended to be used during the flight, the battery must be removed and packaged separately unless the concentrator contains at least two effective protective features to prevent accidental operation during transport.